Folate Analog Metabolic Inhibitor class drugs

4 results

  • Folotyn

    (pralatrexate)
    Acrotech Biopharma Inc
    Usage: FOLOTYN is indicated for treating patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Its approval is based on overall response rates, with continued approval dependent on confirmation of clinical benefits in future trials.

  • Otrexup

    (methotrexate)
    Antares Pharma, Inc.
    Usage: Otrexup is indicated for managing severe, active rheumatoid arthritis in adults and children with polyarticular juvenile idiopathic arthritis, as well as for the symptomatic control of severe psoriasis in adults unresponsive to other treatments. It is not for neoplastic diseases.

  • Rasuvo

    (methotrexate)
    Medexus Pharma Inc.
    Usage: Rasuvo is indicated for managing severe, active rheumatoid arthritis in adults and polyarticular juvenile idiopathic arthritis in children, where first-line treatments are ineffective or intolerable. It also treats severe, recalcitrant psoriasis in adults with an established diagnosis. Not recommended for neoplastic diseases.

  • Xatmep

    (Methotrexate)
    Azurity Pharmaceuticals, Inc.
    Usage: XATMEP is indicated for treating pediatric patients with acute lymphoblastic leukemia (ALL) as part of a chemotherapy regimen and managing active polyarticular juvenile idiopathic arthritis (pJIA) in those who respond inadequately or are intolerant to first-line therapies, including NSAIDs.